Dr. Paul G. Hovsepian, MD

Dr. Hovsepian practices at California Cardiovascular Care Medical Group Inc in Pasadena, California.

Dr. Hovsepian's NPI, 1689616153, was assigned on June 11, 2006. Dr. Hovsepian graduated from St. George's University School of Medicine in 1982. Dr. Hovsepian's California license number on file is A401173.

Dr. Hovsepian's primary practice is California Cardiovascular Care Medical Group Inc, at 3235 E Colorado Blvd, Pasadena, CA 91107 in Los Angeles County. The practice phone is (626) 577-7050.

Dr. Hovsepian's primary practice is California Cardiovascular Care Medical Group Inc in Pasadena, California. Dr. Hovsepian is also affiliated with Emanate Health Inter-Community Hospital. The medical group on file is California Cardiovascular Care Medical Group. Dmand AI also links Dr. Hovsepian to 4 more hospitals, 3 group practices and clinics, 2 medical groups and 1 physician office, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Hovsepian practices, 9 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Hovsepian's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dmand AI has Dr. Hovsepian's licenses on file in 2 states: California and Tennessee.

Dmand AI lists atrial fibrillation and flutter, cardiomyopathy, chronic hypertension, coronary artery disease, heart failure, heart valve disorders, high cholesterol and pacemaker or defibrillator implantation among the conditions Dr. Hovsepian treats.

CMS data shows 3,162 Medicare services from Dr. Hovsepian across 11 procedure codes in 2024, for 700 Medicare patients. Medicare paid $234,244 for them.

CMS counts 700 Medicare patients who saw Dr. Hovsepian in 2024. The largest group is 85 and over, with 283 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 82% are also on Medicaid. Their average risk score is 3.14, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Hovsepian's median patient age at 66, with 53% women.

In 2024, Dr. Hovsepian wrote 358 Medicare Part D claims for 92 patients. 67% of them were for generic drugs. CMS names the drug for 259 of them, across 14 drugs with 11 or more claims each, at $68,387 in total drug cost. In 2023, CMS named 229 claims across 10 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Hovsepian for performance year 2024, reported individually. Dr. Hovsepian accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Coronary angioplasty and stenting: 1 to 10 procedures (CMS shows small counts as a range)

Pacemaker insertion or repair: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 1 paper to Dr. Hovsepian.

CMS Open Payments shows 151 general payments to Dr. Hovsepian from 32 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 71% of the total. Medtronic, Inc. paid the most, $3,471.

Dmand AI lists 1 award for Dr. Hovsepian, most recently CMS Stage 1 EHR in 2013.

Dr. Hovsepian graduated from St. George's University School of Medicine in 1982.

Dr. Hovsepian is in network with 9 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. Medicare plans come from the most carriers, 7. Check the plan with the practice before a visit.